- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.04. | Quipt Home Medical Corp. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 28.03. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.03. | Stocks in Play: Quipt Home Medical Corp | 1 | Baystreet.ca | ||
| 28.03. | Quipt Home Medical Corp: Quipt Home shareholders elect four directors at AGM | 1 | Stockwatch | ||
| 28.03. | Quipt Home Medical Corp.: Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders | 90 | GlobeNewswire (Europe) | CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT) (TSX: QIPT)?, a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| 13.03. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.03. | Quipt Home Medical Corp.: Quipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024 | 1 | GlobeNewswire (USA) | ||
| 16.02. | Earnings call: Quipt Home Medical announces robust Q1 2024 financials | 1 | Investing.com | ||
| 15.02. | Quipt Home Medical Corp reports results for the quarter ended in December - Earnings Summary | 2 | Reuters | ||
| 14.02. | Quipt Home Medical GAAP EPS of -$0.01 beats by $0.01, revenue of $65.4M beats by $1.1M | 2 | Seeking Alpha | ||
| 14.02. | Quipt Home Medical Corp: Quipt Home loses $600,000 (U.S.) in Q1 | 1 | Stockwatch | ||
| 14.02. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14.02. | Quipt Home Medical Corp.: Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71% | 99 | GlobeNewswire (Europe) | CINCINNATI, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care... ► Artikel lesen | |
| 13.02. | Quipt Home Medical Earnings Preview | 1 | Benzinga.com | ||
| 01.02. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 01.02. | Quipt Home Medical Corp: Quipt Home Medical to release Q1 2024 results Feb. 14 | 1 | Stockwatch | ||
| 01.02. | Quipt Home Medical Corp. to Announce Fiscal First Quarter 2024 Financial Results on February 14, 2024 | 2 | GlobeNewswire (USA) | ||
| 08.01. | Scrap to Stacked: Fixably and Quipt Turbocharge Pre-Owned Device Profits With AI-Powered Automation | 210 | ACCESSWIRE | HELSINKI, FINLAND / ACCESSWIRE / January 8, 2024 / Fixably, the leading global provider of repair and service management software, announced a strategic partnership with Quipt, the leading recommerce... ► Artikel lesen | |
| 27.12.23 | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.12.23 | Quipt Home Medical Corp: Quipt Home files preliminary shelf prospectus | 2 | Stockwatch |
Seite:
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 36,620 | +0,52 % | FMC-Aktie mit Kursverlusten (55,0585 €) | Im Minus liegt zur Stunde der Anteilsschein von FMC . Das Papier kostete zuletzt 58,59 US-Dollar. Eine Verbilligung in Höhe von 2,95 US-Dollar müssen derzeit die Aktionäre von FMC hinnehmen. Gegenwärtig... ► Artikel lesen | |
| VITA 34 | 4,600 | +4,55 % | Vita 34 deutlich besser als erwartet - Aktie reagiert eher verhalten. Wieso? | Die Vita 34 AG hat das Jahr 2023 in Anbetracht eines herausfordernden Umfelds aus rein operativer Sicht solide abgeschlossen, so hiess es bei Vorlage der vorläufigen Zahlen am 31. Januar 2024. Insbesondere... ► Artikel lesen | |
| M1 KLINIKEN | 13,750 | 0,00 % | M1 Kliniken weiter auf Wachstumskurs | Die M1 Kliniken AG veröffentlicht vorläufige IFRS-Zahlen zum Geschäftsjahr 2023. Im abgelaufenen Geschäftsjahr konnte die M1-Gruppe ihre Marktposition im Bereich der Schönheitsmedizin weiter ausbauen... ► Artikel lesen | |
| HIMS & HERS HEALTH | 11,260 | -2,89 % | Why Hims & Hers Stock Was Down This Week | ||
| BAXTER | 37,295 | +0,12 % | Baxter's (BAX) New Injectables Aid Its Pharmaceutical Portfolio | ||
| DAVITA | 120,10 | +1,35 % | Aktienmarkt: Kurs der Aktie von DaVita im Minus (122,7371 €) | Der Anteilsschein von DaVita notiert heute etwas leichter. Der jüngste Kurs betrug 132,14 US-Dollar. Für die Aktie von DaVita steht gegenwärtig ein Abschlag von 4,14 Prozent zu Buche. Das Papier verbilligte... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
| ORPEA | 12,208 | -1,20 % | EMEIS PURSUES ITS REFOUNDATION: 2023 Consolidated Financial Results of ORPEA S.A. | Significant improvement in non-financial indicators, with major advances for employees, residents and patients
Health and safety: decline in the work-related accident frequency rate, at 24.8... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,080 | -1,82 % | Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results | SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic... ► Artikel lesen | |
| CYTOSORBENTS | 0,730 | +2,53 % | CytoSorbents: STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting | ||
| SENSEONICS | 0,403 | +3,23 % | Senseonics Holdings, Inc. Announces Data From the Eversense Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for... ► Artikel lesen | |
| NANO-X IMAGING | 9,100 | +0,33 % | Nano-X Imaging LTD.: Nanox Announces AI Software Increases Identification of Patients with Vertebral Compression Fractures, an early sign of Osteoporosis, Up to Six-Fold | - According to early findings in the ADOPT study, Nanox.AI software improves detection of key risk factor for osteoporosis, outperforming UK National Health Service national average - Findings... ► Artikel lesen | |
| BIOCEPT | 6,800 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.11.2023 | The following instruments on Boerse Frankfurt do have their last trading day on 02.11.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.11.2023ISIN NameCA91834N1006 VSBLTY... ► Artikel lesen | |
| UNIVERSAL HEALTH SERVICES | 146,00 | +0,69 % | Universal Health Services-Aktie heute am Aktienmarkt kaum gefragt: Kurs fällt (143,6240 €) | Im US-amerikanischen Wertpapierhandel notiert der Anteilsschein von Universal Health Services gegenwärtig etwas leichter. Zuletzt zahlten Investoren für die Aktie 153,05 US-Dollar. Heute hat sich am... ► Artikel lesen | |
| DELCATH SYSTEMS | 4,520 | +2,26 % | Delcath Systems, Inc.: Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | NEW YORK, April 4, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic... ► Artikel lesen |
Das Unternehmen QUIPT HOME MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 3,460 Euro und damit -0,57 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
